Executive Director, Computational Systems Biology Revolution Medicines IncExecutive Director, Computational Systems BiologyRedwood City, CA$265,000–$331,000 / yearThe individual will lead a team of computational biologists and bioinformaticians focused on acquisition, organization, and analysis of large multi-omics data sets, using both public and proprietary data sources, that will help inform treatment strategies and guide patient stratification for a growing pipeline of RAS(ON) and targeted oncology therapeutics. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Associate Director, Clinical Operations Revolution Medicines IncAssociate Director, Clinical OperationsRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Proven experience working with investigators, external experts and regulatory agencies and oversight of Contract Research Organizations and third-party vendors including realigning with CRO partners when deliverables are at risk, negotiating solutions and leading After Action Reviews to share lessons learned.
Director, Regulatory Affairs - US Filing Lead Revolution Medicines IncDirector, Regulatory Affairs - US Filing LeadRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Required Skills, Experience and Education: Degree in life sciences, pharmacy, medicine, or related fields with a minimum of 12 years in the pharmaceutical/biotech industry or relevant work experience and a minimum of 8 years in Regulatory Affairs including a regulatory strategy role.
Executive Director, Clinical Supply Chain Revolution Medicines IncExecutive Director, Clinical Supply ChainRedwood City, CA$265,000–$331,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Director, US Compliance Revolution Medicines IncDirector, US ComplianceRedwood City, CA$267,000–$306,000 / yearProvide timely, practical, and risk-based compliance advice and counsel on healthcare compliance and policy requirements related to Revolution Medicines interactions with the healthcare community, including disease education programs, promotional and nonpromotional activities, consulting engagements, advisory boards, external funding, patient assistance programs, patient advocacy group interactions, payer interactions, and other similar activities. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Senior Director, Global Patient Safety Surveillance Revolution Medicines IncSenior Director, Global Patient Safety SurveillanceRedwood City, CA$244,000–$305,000 / yearProvide relevant subject matter expertise for the design, development, maintenance, and support of one or more core GPS processes (i.e. comparative benefit-risk, signal detection & management, risk management, aggregate reporting, etc.) in compliance with applicable Good Clinical Practice (GCP), Good Pharmacovigilance Practice (GVP), Good Documentation Practices (GDocP), etc., in alignment with the company's mission and objectives. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
Medical Director, Psychiatry (backed by Y Combinator, $5M+ ARR, $23M+ raised) Legion HealthMedical Director, Psychiatry (backed by Y Combinator, $5M+ ARR, $23M+ raised)San Francisco, CaliforniaThe right person combines the clinical credibility of a leading psychiatrist, the partnership instincts of a healthcare executive, the trust-building judgment of a medical affairs leader, and the product curiosity required to help build AI-native care responsibly. Our technical moat is hard to copy—we combine rich data, production AI, doctors in the loop , and end-to-end care operations to deliver measurably better care to a clinically complex patient population.
Area Business Director Syneos - Commercial - ProdArea Business DirectorSan Francisco, CA$200,000–$225,000 / yearReporting to the Syneos Health National Project Director, the Area Business Director (ABD) will be responsible for achieving business objectives by hiring and leading a team of Institutional Account Managers (IAMs) and Strategic Business Directors (SBDs) in the successful promotion of products to targeted physicians/accounts within an assigned geographic region. Lead Sales and Access individual contributors focused on IDNs and Hospital systems in the U.S. Recruit and hire team of Institutional Account Managers and Strategic Business Directors for designated territories.
Director of Housing Facilities - (Administrator II) - Housing, Dining and Conference Services CSU CareersDirector of Housing Facilities - (Administrator II) - Housing, Dining and Conference ServicesSan Francisco, CaliforniaIn issue/problem prediction, detection, avoidance, mitigation and resolution, including use of appropriate and/or required communication strategies involving stakeholders representing all facets of a large organization and client community (ex: staff, faculty, students, family members, alumni, donors, grantors, local government, community neighbors, emergency service and utility providers, contractors, experts, the general public, media. 7 years of progressively, responsible and successful leadership and management of complex facility operations with responsibility for facilities management, building maintenance and related projects, energy management and conservation, personnel management, professional development and training, industrial safety programs and function-specific financial management in a campus environment.
Associate Director, Biostatistics Clinical Late Stage Revolution Medicines IncAssociate Director, Biostatistics Clinical Late StageRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Director of Regulatory Affairs Epia NeuroDirector of Regulatory AffairsAlameda, CaliforniaAs a Director of Regulatory Affairs you will report to the Chief Executive Officer and be responsible for owning the regulatory strategy and execution end-to-end from early FDA engagement through IDEs and PMA submission and approval, and commercialization. We’re looking for a Director of Regulatory Affairs for our office in Alameda, California who wants to lead, develop and execute the regulatory strategy for Epia Neuro’s Class III implantable neurotechnology.
Director, US Analytics, Lung Revolution Medicines IncDirector, US Analytics, LungRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. This role will partner closely with Commercial, Medical Affairs, Market Access, Clinical Development, and Business Operations to generate actionable insights that inform portfolio strategy, launch readiness, commercialization planning, and business performance.
Senior Director, Head of Transactions & Partnering Revolution Medicines IncSenior Director, Head of Transactions & PartneringRedwood City, CARemote$244,000–$305,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The role partners closely with Business Development leadership and cross-functional stakeholders across Research, Development, Commercial, Finance, Legal, Intellectual Property, and Executive Management to advance high-priority opportunities from initial assessment through successful execution.
Associate Director, Environmental Health and Safety Revolution Medicines IncAssociate Director, Environmental Health and SafetyRedwood City, CA$186,000–$233,000 / yearManage occupational health program activities in partnership with internal stakeholders and external providers, including workplace injury and illness investigation and tracking, animal allergen questionnaire administration and follow-up, hepatitis B vaccination program support, ergonomics program coordination and continuous improvement, and maintenance of related documentation, metrics, and compliance records. Support Facilities Safety Programs through cross-functional collaboration and subject matter expertise, ensuring effective implementation of programs such as electrical safety, lockout/tagout, fall protection, confined space, heat illness prevention, and hot work, while maintaining clear role distinction from program ownership.
NewChief of Branches (0952 - Deputy Director II) - San Francisco Public Library City and County of San FranciscoChief of Branches (0952 - Deputy Director II) - San Francisco Public LibrarySan Francisco, CA$161,382–$205,972 / yearProfessional librarian experience in a libraryExperience working as a member of a library's leadership teamExperience in managing large-scale library branch operationsExcellent management and leadership skillsDemonstrates outstanding political acumenHighly attuned to current trends and future needs of the LibraryAccessible; willingness to engage people at all levels of the organizationFocused on consensus/team buildingDisplays a passion for working with and serving peopleAbility to create and maintain a highly engaged staffEmbraces challenges as opportunities for improvement and positive changeComfortable with interacting and engaging the publicValues individual and collective staff contributions and talentSupports and facilitates ongoing professional developmentPractices unquestionable ethics and integrityEngaging and credible communicatorVerification of Education and Experience: Every application is reviewed to ensure that you meet the minimum qualifications as listed in the job ad. If education or experience verification is required, information on how to verify education and experience requirements, including verifying foreign education credits or degree equivalency, can be found at https://careers.sf.gov/knowledge/experience-education/.Note : Falsifying one's education, training, or work experience or attempted deception on the application may result in disqualification for this and future job opportunities with the City and County of San Francisco.
Senior Director, Clinical Operations, Global Clinical Vendor Contracts & Budgets Revolution Medicines IncSenior Director, Clinical Operations, Global Clinical Vendor Contracts & BudgetsRedwood City, CA$244,000–$305,000 / yearThe leadership role ensures alignment with strategic objectives, regulatory requirements, and study timelines as well as bringing deep expertise in managing complex trials, contract negotiations, budget development, risk management, and cross-functional collaboration to contribute to the highest quality with on time delivery of RevMed's clinical studies. A member of the Clinical Operations team Leading the Contracts and Outsourcing for all vendor relationships within Clinical Development, the Sr Director Global Vendor Outsourcing will lead the strategic identification and selection process with the teams for vendors and CROs, including scope specifications for clinical programs, and will work closely with the Sr.
Associate Director, Clinical Operations Compliance & Training Revolution Medicines IncAssociate Director, Clinical Operations Compliance & TrainingRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies.
Senior Director, Global Value Access and Pricing, NSCLC Revolution Medicines IncSenior Director, Global Value Access and Pricing, NSCLCRedwood City, CARemote$232,000–$290,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. As the Global Value & Access lead on Disease Area Strategy Teams and governance forums, the Senior Director influences clinical development, indication sequencing, lifecycle management, launch planning, and business development decisions to maximize long-term asset value and sustainable patient access.
Director Of Housing Development (Oakland Or Foster City Or Watsonville) MidPen Housing CorporationDirector Of Housing Development (Oakland Or Foster City Or Watsonville)Oakland, CA$193,600–$217,800 / yearSince 1970, we have been committed to our mission: to provide safe, affordable housing of high quality to those in need; establish stability and opportunity in the lives of residents; and foster diverse communities that allow people from all ethnic, social, and economic backgrounds to live in dignity, harmony, and mutual respect. The Director of Housing Development is responsible for managing a team of Real Estate Development personnel including Senior Project Managers, Project Managers, Associate Project Managers and/or Project Associates.
Director, IT Infrastructure & Operations Nurix Therapeutics IncDirector, IT Infrastructure & OperationsBrisbane, CAYou lead a team that spans enterprise architecture, system administration, and cybersecurity operations, with the service desk delivered through a mix of staff and managed service providers. A measurable track record managing a managed service provider portfolio, including real consolidation or vendor transitions with accountability for outcomes.